Fresenius Medical Care AG (FMS) Equity Average (2011 - 2025)

Fresenius Medical Care AG (FMS) has reported Equity Average for 15 consecutive years, with $15.3 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Equity Average fell 3.71% year-over-year to $15.3 billion; the TTM figure through Dec 2025 stood at $15.3 billion (down 3.71% YoY), while the FY2025 annual figure was $16.2 billion, down 1.4% from the prior year.
• Equity Average came in at $15.3 billion for Q4 2025 at Fresenius Medical Care AG, up from $15.1 billion in the prior quarter.
• The five-year high for Equity Average was $16.0 billion in Q1 2025, with the low at $14.2 billion in Q3 2021.
• Average Equity Average over 5 years is $15.1 billion, with a median of $15.1 billion recorded in 2022.
• Across the five-year window, Equity Average grew 8.13% in 2021 and decreased 3.71% in 2025, its largest moves.
• Year by year, Equity Average stood at $15.2 billion in 2021, then grew by 1.72% to $15.5 billion in 2022, then rose by 0.85% to $15.6 billion in 2023, then rose by 1.96% to $15.9 billion in 2024, then declined by 3.71% to $15.3 billion in 2025.
• According to Business Quant data, Equity Average over the past three periods registered $15.3 billion, $15.1 billion, and $15.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.